Neelendu Dey

Dr. Neelendu Dey is an Associate Professor at the Fred Hutchinson Cancer Research Center (Fred Hutch) and the University of Washington School of Medicine. He holds the Kyle Thomas Spane Endowed Chair and serves as a Gastroenterologist at Fred Hutch Cancer Center. His research focuses on the gut microbiome's role in health, disease, and cancer prevention.

Education:

• MD, Yale University School of Medicine (2000–2005)
• BA in Biochemical Sciences, Harvard University (1996–2000)
• Fellowship in Gastroenterology, University of California, San Francisco (2007–2011)
• Residency and Internship in Internal Medicine, University of California, San Francisco (2005–2007)

Research Interests: Dr. Dey investigates how gut microbiota interact with hosts to influence physiology and pathophysiology, particularly colorectal cancer and inflammatory bowel diseases. His lab explores bile acid metabolism’s role in these processes. Current Projects: Development of microbiome-based strategies for cancer prevention, understanding microbial contributions to Juvenile Dermatomyositis, and gut motility regulation via bile acids.

Awards:

• Kyle Thomas Spane Endowed Chair, Fred Hutch

Advising & Grants: While no students are listed, his lab actively pursues NIH-funded research on microbiome-cancer interactions. Collaborations include translational studies linking microbial imbalances to immune-mediated diseases.

Labs/Teams: The Dey Lab at Fred Hutch drives interdisciplinary research at the intersection of microbiology, oncology, and gastroenterology.